Friday, 11 November 2016

{LONGTERMINVESTORS} India Daily: Results; Results, Change in Reco - Sun Pharmaceuticals, Pidilite Industries, City Union Bank; Update

 

 

 

Daily Alerts

Results

Motherson Sumi Systems: Decent results but SMRPBV growth still below par

l

Largely in-line consolidated results; standalone business surprises positively on profitability

l

Building in double-digit revenue growth in both standalone and SMRPBV businesses

l

Fine-tune our earnings estimates; maintain SELL with revised TP of Rs280

Page Industries: 2Q misses as growth moderates

l

2QFY17 results - reasonable but below expectations

l

Segmental performance - continues to do well in women's segments

l

Solid but overvalued; we stay SELLers

Bank of India: Slippages at seven-quarter low; gains support earnings

l

Strong treasury and investment income to the rescue

l

Fresh slippages decline to 4.1%; impaired loans stable at 16.5%

l

Maintain ADD; waiting for stability of the balance sheet

Apollo Tyres: Weak results

l

India business margins better than expected; Europe business surprises negatively

l

Margins to remain steady on stabilizing input costs, volume growth to improve in 2HFY17

l

Slightly cut estimates, but increase TP on rollover to September 2018E EPS; retain BUY

Dhanuka Agritech: Steady ship

l

Revenues growth steady, better than industry demand in the quarter

l

FY2017E revenue growth guidance lowered to 15%; product launch momentum continues

l

Valuations: Fine-tune estimates, increase TP to Rs820; maintain BUY

Gateway Distriparks: Weak market takes sheen off results

l

Rail business - growing share and savings; latter getting passed on in weak market

l

CFS business - margin stabilizes as loss-making assets move towards breakeven

l

Snowman business - large cost provision mars results; capacity utilization bottoming out

l

2QFY17 results: Expectedly weak quarter; cut estimates

HCG: Healthy quarter; all eyes on ramp-up of new facilities

l

Strong growth in existing facilities; EBITDA 4% ahead of estimates

l

Margin profile improving in existing centers; ramp-up of new facilities promising

l

BUY with revised target price of Rs270

Speciality Restaurants: Another weak quarter

l

2QFY17 earnings print: Another weak quarter

l

We drop coverage on SRL, our last published rating was SELL with a TP of Rs75/share

Results, Change in Reco

Sun Pharmaceuticals: Reported PAT strong; modest when adjusted

l

Strong beat on reported; modest beat on adjusted

l

Competitive pressure intensifying in topicals; MK-3222 now critical for long-term growth

l

Downside limited - upgrade a notch to REDUCE

Pidilite Industries: Modest quarter; risk-reward favorable - upgrade to ADD

l

Challenging demand environment and fading RM tailwinds impact performance

l

International business performance weak; profitability weakens across geographies (ex-Brazil)

l

Estimates broadly unchanged; we find risk-reward favorable at these levels - upgrade to ADD

City Union Bank: Recent performance limits upside; downgrade a notch

l

In-line performance driven by stable growth and improving margins

l

Fresh slippages increase 40 bps qoq at 2.3%; gross NPLs move ~10bps qoq to 2.7%

l

Downgrade to REDUCE post recent outperformance; few risks in the horizon

Sector alerts

Banks: Some material relaxations to show corporate banks in better light

l

S4A tweaks provide a new lifeline to NPL cases, albeit with higher provisioning requirement

l

Other tweaks: 5:25 schemes could rise sharply; partly completed projects could get a breather

l

The benefit to positively affect all public banks and ICICI Bank/Axis Bank amongst private banks

l

Resolutions needs to improve; lack of external players forces banks to step in to provide equity

​ 

--
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.

No comments:

Post a Comment